The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Angiogenesis and Tumor Metastasis
Abstract
Angiogenesis, the recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly vascular primary tumors having a higher incidence of metastasis than poorly vascular tumors. Tumor angiogenesis is regulated by the production of angiogenic stimulators including members of the fibroblast growth factor and vascular endothelial growth factor families. In addition, tumors may activate angiogenic inhibitors such as angiostatin and endostatin that can modulate angiogenesis both at the primary site and at downstream sites of metastasis. The potential use of these and other natural and synthetic angiogenic inhibitors as anticancer drugs is currently under intense investigation. Such agents may have reduced toxicity and be less likely to generate drug resistance than conventional cytotoxic drugs. Clinical trials are now underway to develop optimum treatment strategies for antiangiogenic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy
Ezekowitz, R. A. B., Mulliken, J. B., & Folkman, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262203 · Cited by 1,071
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Activated macrophages induce vascular proliferation
POLVERINI, P. J., COTRAN, R. S., GIMBRONE, M. A., & UNANUE, E. R. (1977) · Nature · doi:10.1038/269804a0 · Cited by 810
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 643
Protamine is an inhibitor of angiogenesis
Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.
Butler, T. P., & Gullino, P. M. (1975) · PubMed · Cited by 528
Sidky, Y. A., & Borden, E. C. (1987) · PubMed · Cited by 494
A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment
Crum, R., Szabo, S., & Folkman, J. (1985) · Science · doi:10.1126/science.2416056 · Cited by 488
Identification of an Inhibitor of Neovascularization from Cartilage
Moses, M. A., Sudhalter, J., & Langer, R. (1990) · Science · doi:10.1126/science.1694043 · Cited by 477
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., & Folkman, J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.356 · Cited by 464
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. P. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 463
Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 440
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.
DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., & Taylor, S. M. (1992) · PubMed · Cited by 423
Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C. L., Söker, S., Niknejad, K., Peoples, G. E., & Klagsbrun, M. (1995) · PubMed · Cited by 393
Toi, M., Hoshina, S., Takayanagi, T., & Tominaga, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02904.x · Cited by 391
Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., & Merino, M. J. (1995) · Europe PMC (PubMed Central) · Cited by 386
Murphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570219 · Cited by 351
Weinstat‐Saslow, D., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., & Steeg, P. S. (1994) · PubMed · Cited by 348
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 344
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Fighting Cancer by Attacking its Blood Supply
Folkman, J. (1996) · Scientific American · doi:10.1038/scientificamerican0996-150 · Cited by 328
Inhibition of Cell Motility by Interferon
Brouty-Boyé, D., & Zetter, B. R. (1980) · Science · doi:10.1126/science.6154315 · Cited by 326
Self-citationAngiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., Bochner, B. H., Esrig, D., Nichols, P. W., Taylor, C. R., Cote, R. J., Groshen, S., Dunn, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.219 · Cited by 319
Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N., & Cavenee, W. K. (1994) · Nature Genetics · doi:10.1038/ng1094-171 · Cited by 307
Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., Testolin, A., & Bevilacqua, P. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550507 · Cited by 305
Somatic Mutations in Paroxysmal Nocturnal Hemoglobinuria: A Blessing in Disguise?
Luzzatto, L., Bessler, M., & Rotoli, B. (1997) · Cell · doi:10.1016/s0092-8674(00)81850-4 · Cited by 299
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
Johnson, M. D., Kim, H. C., Chesler, L., Tsao‐Wu, G., Polverini, P. J., & Bouck, N. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600122 · Cited by 288
Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.
Iruela-Arispe, M. L., Bornstein, P., & Sage, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5026 · Cited by 269
Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
Teicher, B. A., Sotomayor, E. A., & Huang, Z. D. (1992) · PubMed · Cited by 260
Wagn, X. (1994) · Cancer Research · Cited by 256
Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., & Arimoto, Y. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.477 · Cited by 246
Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D., & Giavazzi, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.293 · Cited by 235
Ide, A. (1939) · American Journal of Roentgenology · Cited by 234
Angiogenesis and breast cancer metastasis
Ellis, L., & Fidler, I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92774-3 · Cited by 232
Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
Teicher, B. A., Holden, S. A., Ara, G., Sotomayor, E. A., Huang, Z. D., Chen, Y., & Brem, H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570624 · Cited by 231
Khokha, R. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.4.299 · Cited by 220
FERRARA, N., CLAPP, C., & WEINER, R. (1991) · Endocrinology · doi:10.1210/endo-129-2-896 · Cited by 212
Gately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197
Fernig, D. G., & Gallagher, J. T. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)00007-8 · Cited by 196
Klauber, N., Rohan, R. M., Flynn, E., & D'amato, R. J. (1997) · Nature Medicine · doi:10.1038/nm0497-443 · Cited by 196
Yeo, K. T., Wang, H. H., Nagy, J. A., Sioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 194
Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
Claffey, K. P., & Robinson, G. S. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437469 · Cited by 194
Sledge, G. W., Qulali, M., Goulet, R., Bone, E. A., & Fife, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1546 · Cited by 194
Eccles, S. A., Box, G., Court, W. J., Bone, E. A., Thomas, W., & Brown, P. D. N. (1996) · PubMed · Cited by 191
Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M., Brown, P. D. N., & Hardcastle, J. D. (1995) · PubMed · Cited by 183
Specific inhibition of endothelial cell proliferation by thrombospondin
Bagavandoss, P., & Wilks, J. W. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92171-u · Cited by 170
Montgomery, A. M. P., Mueller, B. M., Reisfeld, R., Taylor, S. M., & DeClerck, Y. A. (1994) · PubMed · Cited by 166
Vogel, T., Guo, N., Krutzsch, H. C., Blake, D. A., Hartman, J. R., Mendelovitz, S., Panet, A., & Roberts, D. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530109 · Cited by 153
Tumor Angiogenesis as a Prognostic Factor in Cervical Carcinoma
Wiggins, D. L., Granai, C. O., Steinhoff, M. M., & Calabresi, P. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1062 · Cited by 150
Meininger, C. J., & Zetter, B. R. (1992) · PubMed · Cited by 144
Self-citationGupta, S. K., Hassel, T., & Singh, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7799 · Cited by 141
Funk, S. E., & Sage, E. H. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540108 · Cited by 138
Protease inhibitors: Role and potential therapeutic use in human cancer
DeClerck, Y. A., & Imren, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00460-m · Cited by 135
Imren, S., Kohn, D. B., Shimada, H., Blavier, L., & DeClerck, Y. A. (1996) · PubMed · Cited by 132
Nanus, D. M., Schmitz‐Dräger, B. J., Motzer, R. J., Lee, A. C., Vlamis, V., Cordon‐Cardo, C., Albino, A. P., & Reuter, V. E. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.19.1597 · Cited by 127
The p53 Tumor Suppressor Gene Inhibits Angiogenesis by Stimulating the Production of ThrombospondinPreprint
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.053 · Cited by 123
Proteases Associated with Invadopodia, and Their Role in Degradation of Extracellular Matrix
Chen, W. (2017) · Enzyme and Protein · doi:10.1159/000468616 · Cited by 122
Complex Roles of Matrix Metalloproteinases in Tumor Progression
Powell, W. C., & Matrisian, L. M. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61107-0_1 · Cited by 115
Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology
Jendraschak, E., & Sage, E. H. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0019 · Cited by 113
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
Kohn, E. C., Reed, E., Sarosy, G., Christian, M., Link, C. J., Cole, K. A., Figg, W. D., Davis, P. A., Jacob, J., Goldspiel, B. R., et al. (1996) · PubMed · Cited by 109
Cell adhesion molecules in angiogenesis
Brooks, P. C. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437471 · Cited by 106
Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.
Martin, D. C., Rüther, U., Sanchez-Sweatman, O. H., Orr, F. W., & Khokha, R. (1996) · PubMed · Cited by 98
Kolber, D. L., Knisely, T. L., & Maione, T. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.304 · Cited by 84
Suppression of pulmonary metastasis by angiogenesis inhibitor TNP‐470 in murine osteosarcoma
Mori, S., Ueda, T., Kuratsu, S., Hosono, N., Izawa, K., & Uchida, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610125 · Cited by 75
Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors.
Gagliardi, A. R., Hennig, B., & Collins, D. C. (1996) · PubMed · Cited by 74
The Pharmacokinetics of TNP‐470, a New Angiogenesis Inhibitor
Figg, W. D., Pluda, J. M., Lush, R. M., Saville, M. W., Wyvill, K., Reed, E., & Yarchoan, R. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03680.x · Cited by 59
Watson, S., Morris, T., Parsons, S. L., Steele, R. J., & Brown, P. D. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.549 · Cited by 59
Clinical trials of antiangiogenic agents
Hawkins, M. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199501000-00014 · Cited by 45
Cited by
(1999) · PubMed · Cited by 2,204
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Van Cutsem, E., Tabernero, J., Lakomy, R., Prenen, H., Prausová, J., Macarulla, T., Ruff, P., van Hazel, G. A., Moiseyenko, V., Ferry, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8201 · Cited by 1,402
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Metadata
- Authors
- Zetter, B. R.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1998-02
- Volume
- 49
- Issue
- 1
- Pages
- 407-424
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2158965678
- Cited by
- 1,015
- References
- 90
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.